Neoplasias primarias múltiples de mama y endometrio secundarias a un tratamiento con tamoxifeno. Nuestra casuística

Killackey, 1985, Endometrial adenocarcinoma in breast cancer patients antiestrogens, Cancer Treat Rep, 69, 237 Fisher, 1994, Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14, J Natl Cancer Inst, 86, 527, 10.1093/jnci/86.7.527 Rutqvist, 1995, Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group, J Natl Cancer Inst, 87, 645, 10.1093/jnci/87.9.645 Fisher, 1998, Tamoxifen for prevention of breast cancer: report of th National Surgical Adjuvant Breast and Bowel Project P-1 Study, J Natl Cancer Inst, 90, 1371, 10.1093/jnci/90.18.1371 Berlier, 1998, Uterine side effects of tamoxifen: a need for systematic pretreatment screening, Obstet Gynecol, 91, 40, 10.1016/S0029-7844(97)00591-7 Hellriegel, 1998, Nachsorge bei Mama Karzinom-patientinnen, Empfehlungen einer Konsensus-Tagung, Forum Deutsche Krebsgesellschaft, 10 ACOG Committee, 1996, Number 169, Feb 1996. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists. Tamoxifen and endometrial cancer, Int J Gynaecol Obstet, 53, 197, 10.1016/S0020-7292(96)90115-0 Love, 1999, Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening, J Clin Oncol, 17, 2050, 10.1200/JCO.1999.17.7.2050 Strauss, 2000, Significance of endovaginal ultrasonography in assessing tamoxifen-associated changes of the endometrium, Acta Obstet Gynecol Scand, 79, 697 Curcic, 2000, Transvaginal sonography of the postmenopausal endometrium Med Pregl, 53, 59 Zarbo, 2000, The effects of tamoxifen therapy on the endometrium, Eur J Gynaecol Oncol, 21, 86 Magriples, 1993, High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients, J Clin Oncol, 11, 485, 10.1200/JCO.1993.11.3.485 Van Hooff, 1998, High grade endometrial cancer associated with tamoxifen use, Eur J Cancer, 34, S48, 10.1016/S0959-8049(98)00111-7 Barakat, 1999, Tamoxifen and endometrial cancer: most cancer are early stage and highly curable, Eur J Cancer, 34, S49 Mignotte, 1998, Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study, Eur J Cancer, 34, S46, 10.1016/S0959-8049(98)00110-5 Cummings, 1999, The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple outcomes of raloxifene evaluation, Jama, 281, 2189, 10.1001/jama.281.23.2189 Jubeliner, 2000, The STAR (Study of Tamoxifen and Raloxifene) trial in West Virginia, W V Med J, 96, 602